Decarboxy Gatifloxacin

Decarboxy Gatifloxacin is a derivative of Gatifloxacin, which is a fluoroquinolone antibiotic used to treat bacterial infections. Decarboxy Gatifloxacin is created by the removal of a carboxyl group from Gatifloxacin, resulting in a compound that has improved solubility and bioavailability. Decarboxy Gatifloxacin is used in the treatment of a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It is also effective against certain strains of bacteria that are resistant to other antibiotics. Chemically, Decarboxy Gatifloxacin has a molecular formula of C17H18F2N3O4 and a molecular weight of 369.34 g/mol. Its mechanism of action involves inhibiting bacterial DNA synthesis by targeting the DNA gyrase and topoisomerase IV enzymes. Decarboxy Gatifloxacin is typically administered orally, with a usual dosage of 400mg taken once a day. It is generally well-tolerated, but like all antibiotics, it can cause side effects such as nausea, vomiting, diarrhea, and skin rash. In conclusion, Decarboxy Gatifloxacin is a potent and effective antibiotic that has been widely used in the treatment of bacterial infections. Its unique chemical structure and mechanism of action make it a valuable addition to the arsenal of antibiotics available for the treatment of various infections.